CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

New review paper is published online

Sep 7, 2022

Our paper entitled “A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research” has been published in the Cardio-oncology journal from Springer-Nature and is now accessible online!

Highlights

Paper by HMU accepted in EMBC 2023

A paper, prepared by the HMU team, entitled “A Full Transformer-based Framework for Automatic Pain Estimation using Videos" was accepted in EMBC 2023 that will be held in Syndey Australia, in July 2023. Really glad to participate with one more paper!

Papers accepted in EMBC 2023

Two papers, prepared by the UOI team, entitled “CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity” and "Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting...

CARDIOCARE at the ESC Spring Summit 2023

CARDIOCARE and specifically the latest developments on the management of the elderly multimorbid patient with breast cancer therapy induced cardiac toxicity was presented at the ESC Spring Summit 2023. Really glad to have participated!